BRPI0417578A - composições endoparasiticidas para aplicação tópica - Google Patents

composições endoparasiticidas para aplicação tópica

Info

Publication number
BRPI0417578A
BRPI0417578A BRPI0417578-6A BRPI0417578A BRPI0417578A BR PI0417578 A BRPI0417578 A BR PI0417578A BR PI0417578 A BRPI0417578 A BR PI0417578A BR PI0417578 A BRPI0417578 A BR PI0417578A
Authority
BR
Brazil
Prior art keywords
topical application
compositions
endoparasiticidal compositions
endoparasiticidal
endoparasiticide
Prior art date
Application number
BRPI0417578-6A
Other languages
English (en)
Inventor
Venkata-Rangarao Kanikanti
Thomas Bach
Gertraut Altreuther
Michael Troubel
Hans-Juergen Hamann
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of BRPI0417578A publication Critical patent/BRPI0417578A/pt
Publication of BRPI0417578B1 publication Critical patent/BRPI0417578B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçõES ENDOPARASITICIDAS PARA APLICAçãO TóPICA". A presente invenção refere-se a composições aplicáveis via transdermal contendo depsipeptídeos cíclicos e/ou praziquantel, bem como à sua preparação e ao seu uso para combate de endoparasitas.
BRPI0417578A 2003-12-13 2004-11-30 composições endoparasiticidas, seu uso e seu processo de preparação BRPI0417578B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10358525A DE10358525A1 (de) 2003-12-13 2003-12-13 Endoparasitizide Mittel zur topischen Applikation
PCT/EP2004/013552 WO2005055973A2 (de) 2003-12-13 2004-11-30 Endoparasitizide mittel zur topischen applikation

Publications (2)

Publication Number Publication Date
BRPI0417578A true BRPI0417578A (pt) 2007-03-20
BRPI0417578B1 BRPI0417578B1 (pt) 2015-12-22

Family

ID=34638681

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417578A BRPI0417578B1 (pt) 2003-12-13 2004-11-30 composições endoparasiticidas, seu uso e seu processo de preparação

Country Status (32)

Country Link
US (1) US7763583B2 (pt)
EP (1) EP1694291B1 (pt)
JP (1) JP4842141B2 (pt)
KR (1) KR101272139B1 (pt)
CN (1) CN1893919B (pt)
AR (1) AR046878A1 (pt)
AT (1) ATE447940T1 (pt)
AU (1) AU2004296537B2 (pt)
BR (1) BRPI0417578B1 (pt)
CA (1) CA2548897C (pt)
CR (1) CR8428A (pt)
DE (2) DE10358525A1 (pt)
DK (1) DK1694291T3 (pt)
ES (1) ES2334920T3 (pt)
GT (1) GT200400264A (pt)
HK (1) HK1102915A1 (pt)
HR (1) HRP20100056T1 (pt)
IL (1) IL176151A (pt)
MX (1) MXPA06006594A (pt)
MY (1) MY142044A (pt)
NO (1) NO20063171L (pt)
NZ (1) NZ547837A (pt)
PE (1) PE20050919A1 (pt)
PL (1) PL1694291T3 (pt)
PT (1) PT1694291E (pt)
RU (1) RU2401108C2 (pt)
SI (1) SI1694291T1 (pt)
TW (1) TWI341202B (pt)
UA (1) UA85574C2 (pt)
UY (1) UY28662A1 (pt)
WO (1) WO2005055973A2 (pt)
ZA (1) ZA200604744B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
MX2008012678A (es) 2006-04-07 2008-12-17 Merrion Res Iii Ltd Forma de dosis oral solida que contiene un mejorador.
CA2654566A1 (en) * 2006-06-09 2007-12-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
PE20081406A1 (es) * 2006-12-20 2008-10-17 Schering Plough Ltd Composiciones farmaceuticas de flunixina
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
KR20110007242A (ko) * 2008-05-07 2011-01-21 메리온 리서치 Ⅲ 리미티드 펩티드 조성물 및 그의 제조 방법
WO2010042395A1 (en) * 2008-10-08 2010-04-15 Wyeth Llc Benzimidazole anthelmintic compositions
US20100215743A1 (en) * 2009-02-25 2010-08-26 Leonard Thomas W Composition and drug delivery of bisphosphonates
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
AP2909A (en) 2009-03-17 2014-05-31 Concert Pharmaceuticals Inc Pyrazinoisoquinoline Compounds
WO2011013003A2 (en) 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
CN103476419A (zh) 2011-01-07 2013-12-25 梅里翁第三研究有限公司 口服投药的含铁药物组合物
US8680054B2 (en) * 2011-04-20 2014-03-25 Novartis Ag Suspension type topical formulations comprising cyclic depsipeptide
CN102283843A (zh) * 2011-06-29 2011-12-21 梁晓天 一种吡喹酮外用制剂及其制备方法和应用
JP6185930B2 (ja) * 2011-12-21 2017-08-23 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 非晶質エモデプシド含有製剤
WO2014098619A1 (en) * 2012-12-18 2014-06-26 Donaghys Industries Limited Transdermal parasiticidal formulations
WO2015123480A2 (en) * 2014-02-14 2015-08-20 Dsm Ip Assets B.V. Compositions and methods for the prevention and/or treatment of schistosomiasis
ES2975708T3 (es) 2015-01-29 2024-07-12 Novo Nordisk As Comprimidos que comprenden agonista del GLP-1 y recubrimiento entérico
JP7045191B2 (ja) 2015-05-20 2022-03-31 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
JP6943859B2 (ja) 2015-12-28 2021-10-06 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
JP2020504710A (ja) 2016-11-16 2020-02-13 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides
WO2019091975A1 (en) 2017-11-07 2019-05-16 Bayer Animal Health Gmbh Method for the synthesis of cyclic depsipeptides
CN111346046B (zh) * 2020-03-06 2021-07-09 安徽农业大学 一种含莫西菌素注射用缓释凝胶制剂及制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US281292A (en) * 1883-07-17 onslow
DE2362539C2 (de) 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3619030A1 (de) * 1986-06-06 1987-12-10 Bayer Ag Topisch anwendbare zubereitungen
DE3634755A1 (de) * 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
US5874479A (en) * 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
DE4317458A1 (de) 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4317457A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
NZ260018A (en) 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
US5780487A (en) 1995-08-07 1998-07-14 Amer Moh Samir S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide
DE19601263A1 (de) 1996-01-16 1997-07-17 Bayer Ag Anthelmintische Paste
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel
DE19941024A1 (de) 1999-08-28 2001-03-01 Hartmut Klocke Wirkstoffpräparat für tierärztliche Applikation und Verfahren zu seiner Herstellung
US6340672B1 (en) 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DK1197215T3 (da) 2000-10-10 2006-07-10 Wyeth Corp Anthelmintiske sammensætninger
GB0108485D0 (en) 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
NZ542955A (en) * 2003-04-04 2008-07-31 Merial Ltd At least one macrolide anthelmintic compound and a second anthelmintic agent, such as praziquantel, morantel and/or pyrantel, a non-aqueous solvent and a thickening agent to prevent endo- and ectoparasitic infections

Also Published As

Publication number Publication date
DK1694291T3 (da) 2010-03-15
NO20063171L (no) 2006-07-07
UY28662A1 (es) 2005-07-29
HK1102915A1 (en) 2007-12-07
DE10358525A1 (de) 2005-07-07
KR20060103953A (ko) 2006-10-04
TWI341202B (en) 2011-05-01
RU2401108C2 (ru) 2010-10-10
MY142044A (en) 2010-08-30
PL1694291T3 (pl) 2010-04-30
IL176151A0 (en) 2006-10-05
ZA200604744B (en) 2007-09-26
HRP20100056T1 (hr) 2010-03-31
US7763583B2 (en) 2010-07-27
CN1893919A (zh) 2007-01-10
AR046878A1 (es) 2005-12-28
PT1694291E (pt) 2010-01-18
CR8428A (es) 2006-11-23
TW200533384A (en) 2005-10-16
CA2548897C (en) 2012-04-10
BRPI0417578B1 (pt) 2015-12-22
EP1694291A2 (de) 2006-08-30
JP4842141B2 (ja) 2011-12-21
MXPA06006594A (es) 2006-08-23
KR101272139B1 (ko) 2013-06-10
AU2004296537A1 (en) 2005-06-23
EP1694291B1 (de) 2009-11-11
IL176151A (en) 2013-12-31
CA2548897A1 (en) 2005-06-23
CN1893919B (zh) 2010-09-29
UA85574C2 (uk) 2009-02-10
DE502004010367D1 (de) 2009-12-24
JP2007513903A (ja) 2007-05-31
US20070060509A1 (en) 2007-03-15
SI1694291T1 (sl) 2010-03-31
RU2006124964A (ru) 2008-01-20
NZ547837A (en) 2010-02-26
WO2005055973A2 (de) 2005-06-23
WO2005055973A3 (de) 2005-08-11
PE20050919A1 (es) 2005-12-16
ATE447940T1 (de) 2009-11-15
AU2004296537B2 (en) 2010-05-13
ES2334920T3 (es) 2010-03-17
GT200400264A (es) 2005-08-18

Similar Documents

Publication Publication Date Title
BRPI0417578A (pt) composições endoparasiticidas para aplicação tópica
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
BRPI0508894A (pt) meios para administração transdérmica de nicotina e uso
BR0111667A (pt) Novos compostos
BR0310077A (pt) Novos compostos e sua utilização
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
BR0108678A (pt) Novos compostos
WO2004089396A3 (en) Anti-fungal peptidomimetics
SE0301653D0 (sv) Novel compounds
CL2004000930A1 (es) Compuesto derivado de dihidroquinazolina de formula definida, util para el tratamiento y/o profilaxis de infecciones virales; composicion farmaceutica que comprende al compuesto y uso del compuesto en la preparacion de medicamentos.
CY1111541T1 (el) Αγωνιστες β-2 αδρενοϋποδοχεα για την αγωγη παθησεων συνδετικου ιστου του δερματος
BRPI0510938A (pt) vitamina k1 como energizador em formulações cosméticas
BRPI0407234A (pt) Heterociclos substituìdos
BRPI0620431B8 (pt) uso de poliuretanos lineares carboxilados, integralmente reagidos, neutralizados, preparação farmacêutica líquida, aplicador e emplastro contendo a referida preparação farmacêutica
BRPI0411306A (pt) composições farmacêuticas compreendendo compostos ativos de vitamina d
BRPI0608287A2 (pt) agente endoparasiticida
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
BRPI0408295A (pt) uso de um composto
CR9108A (es) Prevencion de infecciones endoparasitas verticales
BRPI0518554A2 (pt) uso de um inibidor de pde3
BR0111669A (pt) Novos compostos
BRPI0507157A (pt) uso de fator viia ou de um equivalente de fator viia, kit de partes para tratamento de trauma, e, métodos para tratar trauma e para prevenir, tratar trauma
BR0107160A (pt) Uso de um éter cìclico para o preparo de medicamentos que afetam a tolerância à glicose
BR0317947A (pt) Inibidores de quinurenina 3-hidroxilase para o tratamento de diabetes
BRPI0409175A (pt) preparação farmacêutica oral para antagonistas de bombeamento de próton

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER ANIMAL HEALTH GMBH (DE)

Free format text: TRANSFERIDO DE: BAYER HEALTHCARE AG

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: A61K 9/00, A61P 33/00

Ipc: A61K 9/00 (2011.01)

B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/12/2015, OBSERVADAS AS CONDICOES LEGAIS.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2542 DE 24-09-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.